US Patent Issued to Novo Nordisk on Dec. 9 for "Antibodies and use thereof" (American, Danish Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,249, issued on Dec. 9, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Antibodies and use thereof" was invented by Peter Matthew Tessier (Saline, Mich.), Samuel D. Stimple (Boston) and Arne Staby (Bagsvaerd, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils."

The patent was filed on Nov. 19, 2021, under Application No. 17/530,974.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%...